1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Atrial Fibrillation Recurrent: new trials by email Literature Review of Atrial Fibrillation Recurrent trials Research Report on Atrial Fibrillation Recurrent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation Dapagliflozin 10 mg [Farxiga] - Atrial Fibrillation Recurrent, Catheter Ablation | Phase 2 / Phase 3 | Active not recruiting | Chang Gung Memorial Hospital | 196 | 2023-12-01 | 2023-12-21 |
dapagliflozin (1)
Chang Gung Memorial Hospital (1)
Taiwan (1)
Yung-Lung Chen (1)